Iodex goes to SmithKline Beecham consumer Healthcare
Iodex is the market leader in the pain-balm segment, with a market share of 70 per cent-plus. Iodex faces challenges from local brands like Amrutanjan, Tiger Balm (locally manufactured by Elder Pharma), Zandu Balm and Sensur of Glenmark. //
Glaxo SmithKline India (GSK) has decided to transfer...
Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
...n 2005. In 2004, IBC Conferences named him Chief Scientific Officer of the Year.
Prior to joining Wyeth, Dr. Ruffolo spent 17 years at SmithKline beecham
(now GSK) and 6 years at Lilly Research Laboratories. During his career, Dr. Ruffolo played a significant role in the discovery and/or development of ...
Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May
...cutive positions with American Cyanamid, Inc., Diane Von Furstenburg, Inc., beecham
Cosmetics, Inc., Gale Hayman, Inc., and Savvy International, Inc. In parti...ch of the highly successful Pierre Cardin men's line and the acquisition by beecham
Cosmetics of Diane Von Furstenburg, Inc. We believe that Mr. Savage's lead...
John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer
...kcorp, a financial services holding company located in Kentucky.
Mr. Davis has worked in various IT positions for companies such as Smith Kline beecham
and Blue Cross and Blue Shield of Maryland. He holds an MBA from Drexel University , with a concentration in International Business.
Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer
...anning and business development while at Inotek Pharmaceuticals Corp., Exact Sciences Corp., Pathogenesis Corp. (now part of Novartis), and SmithKline beecham
(now part of GlaxoSmithKline).
"I am looking forward to working with Dr. Celniker and the rest of the team that she has assembled as we buil...
Watson Pharmaceuticals Reports Third Quarter 2008 Results
Risperdal(R) is a registered trademark of Johnson & Johnson Corporation. Lamictal(R) is a registered trademark of SmithKline beecham
The following table presents Watson's results of operations for the
three and nine months ended September 30, 2008 and 2007:
Smart Balance Announces Marketing Organization Appointment
...ading manufacturer of composite
decking. Prior to that he held senior leadership roles with Mead
Johnson/Bristol-Myers Squibb, Rite Aid and Smithkline beecham
Healthcare. McWilliams has a BA from Westminister College and an MBA from
Harvard Graduate School of Business.
The Company issued to McWill...
Paul Capital Partners Promotes Ken Macleod To Partner
...maceutical and biotechnology industries, where he previously held
senior management positions over a 15-year career at Serono, Abbott
Laboratories and beecham
Pharmaceuticals. Prior to joining Paul Capital
Partners, Dr. Macleod was a Venture Partner at Schroder Ventures Life
Sciences where he was responsible...
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
...ons Manager for Scherer DDS (a division of RP Scherer) from
1994 to 1999; and various European clinical research positions with Beecham
and SmithKline beecham
and GH Besselaar from 1983-1994. Dr. Clarke holds a
Bachelors of Science in Pharmacology from University of Sunderland and a
PhD in Psychopharmacology...
PhRMA Celebrates 20th Anniversary of Discoverers Award
...es exemplify the best among research based company
This year, PhRMA presented the Discoverers Award to the three then
scientists who discovered the prescription drug Coreg.
The recipients of the award are Eliot Ohlstein, Ph.D., Senior Vice
President and head of the Ca...
Beecham in Medical Technology
Beecham in Biological Technology
Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
...lopment, and was later appointed Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals. Following the merger of SmithKline beecham
with Glaxo Wellcome in 2000, he returned to the United States as Senior Vice President for Worldwide Business Development.
Dr. Greig also serves ...
Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development
...toral Fellowship at The Wistar Institute. Previous to joining Axial Biotech, Dr. Macina worked with the molecular diagnostics department at SmithKline beecham
in the discovery and characterization of novel genes differentially expressed in different cancers.
"Dr. Macina's decision to join Axial streng...
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
...roduct development, R&D operations, corporate development and strategy, as well as new product research. Prior to Nektar, he worked at SmithKline beecham
Pharmaceuticals in King of Prussia, PA, where he focused in the areas of pharmaceutical technology formulation sciences and product development.
GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
...itation and the tender offer to buy shares of Genelabs is only being made pursuant to the Offer to Purchase and related materials that GSK, SmithKline beecham
Corporation and Gemstone Acquisition Corporation filed with the Securities and Exchange Commission (SEC) on November 12, 2008 and as subsequently amen...
GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
...ffer in connection with the addition of
Corporation, a wholly-owned subsidiary of GSK, as ...s, Gemstone Acquisition Corporation and SmithKline beecham
All other terms and condition...urchase
and related materials that GSK, SmithKline beecham
Corporation and Gemstone
Acquisition Corporation f...
GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.
...pursuant to a previously announced Agreement
and Plan of Merger dated October 29, 2008 among Genelabs, Gemstone Acquisition
Corporation and SmithKline beecham
Corporation, a wholly-owned subsidiary of
All other terms and conditions of the tender offer remain the same,
including the condition tha...
GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.
...der offer is being made pursuant to a previously announced
Agreement and Plan of Merger dated October 29, 2008 among Genelabs,
Gemstone and SmithKline beecham
Corporation, a wholly-owned subsidiary of
The Genelabs board of directors has unanimously determined that the
tender offer and the merger are f...
David M. Stout Joins NanoBio Corporation's Board of Directors
...ing to respond to a global influenza pandemic.
Prior to his tenure at GSK, Mr. Stout held executive leadership positions
at Glaxo Wellcome, SmithKline beecham
and Schering-Plough Corporation.
NanoBio(R) Corporation is a privately held biopharmaceutical company
focused on developing and comm...
QuoNova Global Executive Appointments
...ntree Laboratories, a
$100 million deal. Michael's background includes business development roles
with International Clinical Laboratories, SmithKline beecham
and Integrated Genetics/Genzyme Corporation. He has a BA in Chemistry from
Assumption College in Worcester, Massachusetts and an MBA from...
Warner Chilcott Reports the Death of Its Director James Andress
...ng he also served as the co-chairman
of the audit committee of the board of directors. Mr. Andress was a former
Chairman of the Pharmaceuticals Group, beecham
Group, plc, former Chairman,
Healthcare Products and Services of SmithKline Beecham, plc and former
President and Chief Operating Officer of Sterling ...